Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data.
作者信息
Faden Daniella F, Xie Lillian, Stone Caroline J, Lopes Almeida Gomes Lais, Eldaboush Ahmed, Ricco Cristina, Feng Rui, Werth Victoria P
机构信息
Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
J Am Acad Dermatol. 2024 Dec;91(6):1203-1205. doi: 10.1016/j.jaad.2024.07.1478. Epub 2024 Jul 31.
Abstract
摘要
相似文献
1
Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data.皮肤型红斑狼疮：基于生活质量数据扩大临床试验纳入标准。
J Am Acad Dermatol. 2024 Dec;91(6):1203-1205. doi: 10.1016/j.jaad.2024.07.1478. Epub 2024 Jul 31.
2
Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.马来西亚一家三级皮肤科中心的皮肤红斑狼疮患者的临床组织学和免疫病理学特征。
Clin Exp Dermatol. 2022 Aug;47(8):1490-1501. doi: 10.1111/ced.15190. Epub 2022 May 23.
3
The impact of skin damage due to cutaneous lupus on quality of life.皮肤狼疮导致的皮肤损伤对生活质量的影响。
Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.
4
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.评估疾病活动的变化对于皮肤红斑狼疮临床试验中反映生活质量的有意义改善是必要的。
J Am Acad Dermatol. 2021 Jun;84(6):1562-1567. doi: 10.1016/j.jaad.2020.07.047. Epub 2020 Jul 16.
5
Subtype and Racial Erythema Variation for Cutaneous Lupus Trials.皮肤狼疮试验的亚型及种族性红斑变异
JAMA Dermatol. 2025 Jan 1;161(1):67-74. doi: 10.1001/jamadermatol.2024.5190.
6
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.采用修订版 Wilson 和 Cleary 模型评估红斑狼疮患者生活质量的相关因素。
Lupus. 2020 Nov;29(13):1691-1703. doi: 10.1177/0961203320951842. Epub 2020 Sep 3.
7
Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.皮肤型红斑狼疮和皮肌炎的流行病学及临床评估工具的最新进展
Curr Dermatol Rep. 2013 Mar;2(1):48-57. doi: 10.1007/s13671-012-0037-3. Epub 2013 Jan 24.
8
Severity Scores for Cutaneous Lupus Erythematosus.红斑狼疮皮肤损伤严重程度评分。
J Invest Dermatol. 2024 Nov;144(11):2354-2363. doi: 10.1016/j.jid.2024.07.032. Epub 2024 Sep 14.
9
Impact of smoking in cutaneous lupus erythematosus.吸烟对皮肤型红斑狼疮的影响。
Arch Dermatol. 2012 Mar;148(3):317-22. doi: 10.1001/archdermatol.2011.342. Epub 2011 Nov 21.
10
Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan.评估日本皮肤病变红斑狼疮患者的生活质量。
Lupus. 2014;23(1):93-101. doi: 10.1177/0961203313509293. Epub 2013 Nov 6.
本文引用的文献
1
The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.CLASI，一种用于评估红斑狼疮皮肤疾病的有效工具：叙述性综述。
Ann Transl Med. 2021 Mar;9(5):431. doi: 10.21037/atm-20-5048.
2
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.评估疾病活动的变化对于皮肤红斑狼疮临床试验中反映生活质量的有意义改善是必要的。
J Am Acad Dermatol. 2021 Jun;84(6):1562-1567. doi: 10.1016/j.jaad.2020.07.047. Epub 2020 Jul 16.
3
The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus.系统性红斑狼疮患者随机临床试验中性别和种族/族群的代表性。
Curr Rheumatol Rep. 2018 Mar 17;20(4):20. doi: 10.1007/s11926-018-0728-2.
4
Quality of life in cutaneous lupus erythematosus.皮肤红斑狼疮的生活质量。
J Am Acad Dermatol. 2011 May;64(5):849-58. doi: 10.1016/j.jaad.2010.02.008. Epub 2011 Mar 12.
5
Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus.开发CLASI作为一种用于衡量皮肤红斑狼疮疾病严重程度和对治疗反应性的工具。
Arch Dermatol. 2011 Feb;147(2):203-8. doi: 10.1001/archdermatol.2010.435.
Zotero 插件